The Possibility for Immunotherapy in Neoadjuvant Bladder Cancer Treatment

Geoffrey Sklar, MD, Chief Medical Officer, Chesapeake Urology Associates, discusses the possibility for immunotherapy as a neoadjuvant treatment in bladder cancer.